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wo the Editor: Presently, occurrence of late stent thrombosis (LST)
fter drug-eluting stent implantation is a major clinical concern.
lthough LST is an infrequent complication, LST can lead to
erious results. A long-term follow-up study revealed recently that
ST occurs at a constant rate of 0.6%/year for up to 3 years after
rug-eluting stent implantation (1). Regarding pathological con-
iderations, a delayed arterial healing characterized by incomplete
ndothelialization and persistence of fibrin plays a key role in the
ccurrence of LST. Moreover, the best morphometric predictor of
ST after drug-eluting stent implantation is a ratio of uncovered
truts to total struts/section of 0.3 (2). Therefore, we hypothe-
ized that the uncovered struts of sirolimus-eluting stent (SES)
emain for an extended period of time.
Optical coherence tomography (OCT) with high-resolution
mages (approximately 10 m) can clearly distinguish thin neoin-
imal hyperplasia (NIH) on stent struts and uncovered struts (3).
o date, no long-term OCT follow-up data after SES implanta-
ion are available. The present OCT examinations focused on the
requency of uncovered struts of the SES at 2-year follow-up.
Between February 2007 and May 2007, 2-year angiographic
nd OCT follow-up examinations after SES (Cypher, Cordis
orp., Miami Lakes, Florida) implantation were performed for 21
egments in 21 patients (age 64  10 years, 18 male). During this
tudy period, clopidogrel had not been approved for clinical use in
apan.
The OCT procedure has been previously reported (3). Cross-
ectional OCT images were analyzed at intervals of 1 mm.
hickness of NIH inside all struts was measured, and thickness 
m was defined as uncovered. Uncovered strut ratio in each
ross-section was calculated as uncovered strut ratio  uncovered
trut(s)/total struts (Fig. 1). In-stent thrombus was defined as an
rregular mass protruding into the lumen that had dimension
250 m at its thickest point. Continuous data are presented as
ean  SD. Fisher exact test or unpaired t test was used for
tatistical analysis.
In 485 cross-sectional images, 3,707 struts were identified.
hickness of NIH was 71 93 m. Frequency of uncovered struts
as 5% (range 0% to 12%/patient). In the bifurcations, of the 39
truts located in the orifice of side branches 4 (10%) were
ncovered. In the overlapping segments, 19 of 286 (7%) struts
ere uncovered. Prevalence of patients who had any uncovered
truts was 81%. Uncovered strut ratio/patient ranged from 0 to
.43. Frequency of cross-section(s) with uncovered strut ratio0.3
as 2%. Concerning these cross-sections, 2 were in the overlap-
ing segments and none was in the bifurcation. Prevalence ofatients who had any cross-sections with uncovered strut ratio
0.3 was 38% (Fig. 2).
The OCT identified 3 thrombi in 3 patients. There were no
bnormal findings on coronary angiograms. None of these cases
howed any clinical thrombus-related events. Among these pa-
ients, 2 received dual antiplatelet therapy and another patient was
rescribed aspirin monotherapy. Uncovered struts or cross-sections
ith uncovered strut ratio 0.3 were recognized in 1 patient.
In our series, 2% of the uncovered struts in 81% of the patients
till remained 2 years after SES implantation. These frequencies
ere higher than in bare metal stents (0.1% of the struts in 7% of
he patients; Takano et al., unpublished data). Moreover, 38%
f the patients had the cross-section of uncovered strut ratio 0.3,
he most powerful pathological predictor of LST. However,
o thrombotic events occurred in any patient. There was a possibility
hat existence of these cross-sections was not an absolute condition
ut a necessary condition for the occurrence of LST. In other
ords, under the condition of existence of these poorly covered
Figure 1 Uncovered Struts,
Thrombus, and Tissue Around Struts
There were 14 stent struts on this cross-section, and 5 struts had no neointima
(uncovered struts; arrows). Uncovered strut ratio was 0.36. Some struts were sur-
rounded by intracoronary structures with an irregular surface (arrowheads).
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March 4, 2008:968–73ross-sections, additional special factors, such as discontinuation of
ntiplatelet therapy, antiplatelet resistance, intrinsic thromboge-
icity, or coronary flow problems might trigger the development
f LST.
In comparison with previous data of 3-month follow-up (pa-
ients n 21, struts n 4,545) (3), thickness of NIH in the 2-year
ollow-up group was greater than that in the 3-month follow-up
roup (71  93 m vs. 29  41 m, respectively; p  0.00001).
requency of uncovered struts was lower in the 2-year group than
n the 3-month group (5% vs. 15%, respectively; p  0.00001).
oreover, the prevalence of patients with cross-section(s) of
ncovered strut ratio 0.3 was lower in the 2-year group than in
he 3-month group (38% vs. 76%, respectively) (Fig. 2). Clinical
haracteristics were similar between the 2 groups. From this
erspective, neointimal coverage inside the SES progressed, and
ncovered stent struts decreased from 3-month to 2-year follow-
p. In contrast, prevalence of patients with uncovered struts did
ot differ between the 3-month group and the 2-year group (95%
s. 81%, respectively) (Fig. 2). Despite the fact that neointimal
overage advanced, a few troublesome stent struts might persist as
ncovered struts for up to 2 years.
Two thrombi inside the SES were identified in patients who did
ot have an uncovered strut. Cross-sectional OCT images might
ave a limitation in identification of the uncovered struts under
n-stent thrombi. Intracoronary structures inside the SES, except
or distinct thrombi, were regarded as NIH in this OCT analysis.
owever, it was possible that some tissue of fluffy appearance
Fig. 1) was not NIH but was actually fibrin deposition. Unfortu-
ately, no method of distinguishing fibrin layer from NIH around
he struts in living patients has been established. Additionally,
here is no confirmation that morphological intracoronary struc-
ures have mature endothelial function, such as an antithrombotic
unction. Although OCT is used, evaluation for the uncovered
truts might be underestimated in the situation of fibrin deposition
Figure 2 Prevalence of Patients With Uncovered Struts
The prevalence of patients with uncovered strut(s) did not differ between the
3-month follow-up group (blue bars) and the 2-year follow-up group (yellow
bars). In contrast, prevalence of patients with cross-section(s) of uncovered
strut ratio 0.3 was lower in the 2-year group than in the 3-month group.r thrombus adhesion to the struts. dIn conclusion, long-term follow-up OCT examination demon-
trated that few uncovered struts remained in the majority of the
atients for up to 2 years after SES implantation. Further careful
ollow-up might be required.
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Letters to the Editor
-Wave Alternans
nd Intraventricular
onduction Delays
read with great interest the study by Cantillon et al. (1) on the
tility of microvolt T-wave alternans (MTWA) in predicting total
ortality and arrhythmia-free survival in patients with a left
entricular ejection fraction 30% who had been referred for
nvasive electrophysiological testing for evaluation of syncope
nd/or nonsustained ventricular tachycardia. It is not clear to this
eader whether this report’s database derives from the one em-
loyed in another study, emanating from the same laboratory, and
ublished in another journal on the same month as the present
tudy (2). However, even if this is the case, the present study
rovides an opportunity to evaluate the influence of the QRS
uration on the magnitude of the MTWA. The authors in both
tudies (1,2) employed the traditional threshold of 1.9 V,
erived from the spectral analysis of the signal, to characterize an
